View Cart (0 items)

Pharmaceutical

Pfizer Lung Cancer Pill May Double Survival

The Associated Press reports that a much-anticipated drug for advanced lung cancer from Pfizer Inc. appears to double survival over standard drugs against tumors with a certain genetic mutation, according
Read More

Pfizer Asks EU to Approve Kidney Cancer Drug

The Associated Press reports that Pfizer Inc. has asked European Union regulators to approve its drug candidate axitinib as a treatment for kidney cancer. Pfizer wants approval to market axitinib
Read More

Optimer Wins US Approval for Drug to Fight Fatal Bacteria

According to Bloomberg, Optimer Pharmaceuticals won FDA approval for the first antibiotic in a quarter-century that fights a deadly bacterium linked to intestinal infections often caught in hospitals. Optimer will
Read More

Syngenta Launches New Seed Treatment

According to PRNewswire, Syngenta announced the launch of VIBRANCE™, a proprietary seed treatment fungicide based on the new active ingredient sedaxane. VIBRANCE, which has been tailored specifically for the seed
Read More

Japan''s Takeda Buying Nycomed for $13.6 billion

The Associated Press reports that Takeda Pharmaceutical Co. will buy Switzerland''s Nycomed for $13.6 billion, giving Japan''s biggest drugmaker coveted access to emerging markets. The all-cash deal is the largest
Read More

Amylin Pharmaceuticals Files Suit Against Eli Lilly

PRNewswire reports that Amylin Pharmaceuticals, Inc. has filed a lawsuit against Eli Lilly and Company in the United States District Court for the Southern District of California, alleging that Lilly
Read More

Merck Serono Pays $44 Million to Settle Kickback Charge

The Department of Justice said that multinational drugmaker Merck Serono SA has agreed to pay $44.3 million to settle allegations that it illegally promoted one of its drugs using kickbacks
Read More

Pfizer CEO Read Considering Sale of Four Divisions

Bloomberg reports that Pfizer Chief Executive Officer Ian Read is reviewing the possible sale or spinoff of four divisions with $18.3 billion in annual revenue, led by the company’s third-biggest
Read More

Allergan Loses $212 Million Lawsuit Over Botox Side Effects

According to Bloomberg, Allergan Inc. was ordered by a Virginia jury to pay $212 million to a 67-year-old man who said he got permanent brain damage after being injected with
Read More

SEC Probing Ex-Berkshire Executive Sokol

According to Reuters, the Securities and Exchange Commission is probing former Berkshire Hathaway executive David Sokol, who has been under scrutiny for his trading in Lubrizol, a person familiar with
Read More